GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theragenics Corporation (FRA:THX) » Definitions » YoY EPS Growth

Theragenics (FRA:THX) YoY EPS Growth : -100.00% (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Theragenics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Theragenics's YoY EPS Growth for the quarter that ended in Jun. 2013 was -100.00%.

Theragenics's Earnings per Share (Diluted) for the three months ended in Jun. 2013 was €0.00.


Theragenics YoY EPS Growth Historical Data

The historical data trend for Theragenics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragenics YoY EPS Growth Chart

Theragenics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,219.66 104.73 -27.42 51.11 -22.06

Theragenics Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.86 -27.27 -233.33 -100.00 -100.00

Theragenics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Theragenics's YoY EPS Growth for the fiscal year that ended in Dec. 2012 is calculated as:

YoY EPS Growth (A: Dec. 2012 )
=(Earnings per Share (Diluted) (A: Dec. 2012 )-Earnings per Share (Diluted) (A: Dec. 2011 ))/ | Earnings per Share (Diluted) (A: Dec. 2011 ) |
=(0.053-0.068)/ | 0.068 |
=-22.06 %

Theragenics's YoY EPS Growth for the quarter that ended in Jun. 2013 is calculated as:

YoY EPS Growth (Q: Jun. 2013 )
=(Earnings per Share (Diluted) (Q: Jun. 2013 )-Earnings per Share (Diluted) (Q: Jun. 2012 )) / | Earnings per Share (Diluted) (Q: Jun. 2012 )) |
=(0-0.016)/ | 0.016 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theragenics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Theragenics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Theragenics (FRA:THX) Business Description

Traded in Other Exchanges
N/A
Address
Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.

Theragenics (FRA:THX) Headlines

No Headlines